Corporate Banner
Satellite Banner
Technology Networks Header
Monday, April 21, 2014
Technology Networks
 
Register | Sign in
Home Page > Videos > Emerging Outsourcing Destinations: Pharmas Strategies and Growth Drivers
  Videos

Return

Emerging Outsourcing Destinations: Pharmas Strategies and Growth Drivers
JZMed

Jim Zhang, President, JZMed

Abstract
Emerging markets have been recognized as the key growth driver of the global pharmaceutical market.  They have thus received increasing attention from almost all drug companies around the world.  In addition to the attraction of the fast growing pharmaceutical market, the availability of a variety of outsourcing services at relatively low cost with increasing service capability and improved quality, is also attracting drug companies from all over the world to look for the outsourcing or collaboration opportunities in these countries, in particular China and India.  Currently, a large number of drug companies from all over the world are aggressively looking for partnerships with local companies or research organizations.  Meanwhile, to meet the high demand by the global drug companies and to position them well in these fast growing pharma outsourcing markets, almost all world major CROs and CMOs have made significant investments in these emerging countries.  This presentation will discuss in detail a series of new outsourcing strategies currently pursued by the global drug companies in these key emerging outsourcing countries and the strengths and weakness of the local service providers.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Domainex Programme Shows Great Promise for the Treatment of Inflammatory Diseases
Company’s IKKe/TBK1 programme to offer a disease-modifying treatment for COPD patients.
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Blocking DNA Repair Mechanisms Could Improve Brain Cancer Therapy
The findings were published April 7 in Nature Communications.
Aspirin Does Not Prevent Pregnancy Loss, NIH Study Finds
Increased live birth rate in subgroup of participants.
Statins Slow the Progression of Advanced MS in Clinical Trial
The work is published in the Lancet.
Researchers Discover Underlying Genetics, Marker for Stroke, Cardiovascular Disease
NIH-funded findings point to new potential strategies for disease prevention, treatment.
New Clinical Study on the Relationship Between Imaging and OVA1®
New analysis explores interactions between clinical risk factors used in pre-surgical assessment.
Statins Slow the Progression of Advanced MS in Clinical Trial
The work is published in the Lancet.
Sepsis Study Comparing Three Treatment Methods Shows Same Survival Rate
NIH-funded clinical trial tested specific protocols against usual high-level care.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv